
...

By Kevin Sabet
President, Foundation for Drug Policy Solutions
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
I addressed the United Nations' 68th session of the Commission on Narcotic Drugs last week. My message was simple: Nations must reaffirm their commitment to discouraging drug use and promoting health and safety, in accord with the long-standing principles established under the three international drug policy conventions. Amid calls for radical reform and the legalization of all drugs, it is vitally important to uphold health-first drug policies at the international level.
Policymakers must work tirelessly to prevent kids from beginning drug use and help people with addiction to achieve recovery—this is the most cost-effective and humane way out of the scourge of addiction. We must resolutely reject the trend toward the normalization of drug use.
Efforts based on global cooperation, supply reduction, and the criminal justice system are equally important. More than 100,000 Americans die from overdose every year. Policymakers must face drug cartels head-on in order to keep their lethal drugs out of our neighborhoods—and out of the hands of our kids. The designation of cartels as Foreign Terrorist Organizations, if utilized properly, opens the door to better eliminate these threats.
Read More
GOP Rep: Tariffs Necessary To Win the War on Fentanyl | Opinion4 min read

Congress Can’t Wait—Reform Pharmacy Benefit Managers and Deliver Lower-Cost Drugs for Patients | Opinion3 min read

Americans Are Going Rogue in Response to a Broken Health Care System | Opinion5 min read

All of our drug policies must remain oriented toward discouraging drug use. When fewer people use drugs, fewer will be harmed by them. Drug use affects all aspects of a community and results in a reduced quality of life. I reminded national delegations that there is no such thing as safe illicit drug use.
I was also honored to preview a new Blueprint for Effective Drug Policy, dubbed the Hyannis Consensus, which will outline a comprehensive approach policymakers can take to address the drug crisis. It is our hope that this report—based on the recommendations of nearly 100 experts—will serve as a roadmap to guide future financial and legislative decisions.
We reject the false dichotomies that persist in the drug policy field. Too many pit the criminal justice system against the public health system—both are necessary. Likewise, we reject the false dichotomy between legalization and criminalization, as well as between harm reduction and treatment. Policies must be tailored to respond to the specific situation at hand and updated over time. For example, the drug court model positions the criminal justice system to connect individuals with substance use disorder to life-saving treatment and social services.
Many recognize the need for a new approach to drug policy. Between 2000 and 2023, the number of overdose deaths in the United States increased five-fold from 17,415 to 105,007. In 2023, more than 70 million Americans used an illicit drug, ranging from cocaine and marijuana to fentanyl and meth. These aren't just statistics; they represent parents, children, neighbors, and coworkers.

...
Unfortunately, some activists are pushing for policies that threaten to make the drug crisis even worse. Oregon's failed experiment with the decriminalization of all drugs—including fentanyl, cocaine, and meth—is a case in point. This radical policy caused overdoses, public drug use, and crime to skyrocket, leading public opinion to turn sharply against it. Last year, with our help, the state's Democratic leaders—who had been leading supporters of this policy—backtracked and recriminalized drug possession.
We're also concerned by the more extreme "harm reduction" policies in Canada. Some activists there believe in providing unadulterated drugs, as well as syringes, crack pipes, and a space for people to use them. Lawmakers recently walked back the most radical aspects of this policy amidst fierce backlash. Desperation is leading to experimentation with policies that lack supporting evidence.
Nations are also being lobbied by multinational for-profit industries. They have gone from so-called "medical" marijuana to "recreational" marijuana and now to psychedelics. Don't be surprised if you begin hearing calls for legal cocaine and heroin. These groups won't stop until all drugs are available for recreational drug use. We've already seen how this ends, based on our experience with tobacco and alcohol in the U.S.
But there are certainly points of optimism in our fight to overcome the drug crisis. Countries like Thailand and Germany are working to undo their plans to legalize marijuana. Other nations, led by politicians who are keeping public health in mind, are continuing to reject industry-backed proposals. At global forums like the Commission on Narcotic Drugs, competing factions should remain focused on promoting health and safety, not private profits.
Of course, we Americans must address the drug crisis at home before showing other countries how they can address theirs. This is not a toxic drug crisis or a poisoning crisis—it is a drug crisis, a consequence of millions of Americans' use of life-threatening drugs. The only way out is to get people to stop using drugs, by preventing use and helping current users to quit.
To overcome this situation, policymakers should follow the recommendations of the Hyannis Consensus: invest in prevention, treatment, recovery, and supply reduction. All of these steps will ultimately make it harder for people to purchase and use drugs, which will drive down the prevalence of use and increase health and safety. The Trump administration should incorporate these principles into its forthcoming National Drug Control Strategy.
Nations must pursue better drug policies, guided by a commitment to discouraging drug use and promoting health. Calls to legalize and commercialize drugs like cocaine (I am looking at you, Colombia), marijuana, and psychedelics should be summarily rejected. A continued focus on prevention, treatment, and recovery will help more people to become better individuals, workers, family members, and community members.
Dr. Kevin Sabet is the President of the Foundation for Drug Policy Solutions and a former three-time White House drug policy advisor.
The views expressed in this article are the writer's own.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines